Matthew K. Fust - Mar 31, 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact
Stock symbol
ATRA
Transactions as of
Mar 31, 2024
Transactions value $
$0
Form type
4
Date filed
4/2/2024, 06:13 PM
Previous filing
Mar 22, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Award $0 +150K +137.61% $0.00 259K Mar 31, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units shall vest on the date of the Issuer's annual meeting of stockholders for the calendar year 2025, subject to the Reporting Person's continuous service.